170 related articles for article (PubMed ID: 24725485)
21. [Screening for prostate cancer: why, how?].
Soulié M; Salomon L
Rev Prat; 2013 Apr; 63(4):469-71, 473, 475 passim. PubMed ID: 23682467
[TBL] [Abstract][Full Text] [Related]
22. Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy.
Hoffman KE; Nguyen PL; Ng AK; D'Amico AV
J Urol; 2010 May; 183(5):1798-802. PubMed ID: 20299039
[TBL] [Abstract][Full Text] [Related]
23. PSA and the family physician.
Barkin J
Can J Urol; 2011 Apr; 18 Suppl():20-3. PubMed ID: 21501547
[TBL] [Abstract][Full Text] [Related]
24. American Cancer Society guideline for the early detection of prostate cancer: update 2010.
Wolf AM; Wender RC; Etzioni RB; Thompson IM; D'Amico AV; Volk RJ; Brooks DD; Dash C; Guessous I; Andrews K; DeSantis C; Smith RA;
CA Cancer J Clin; 2010; 60(2):70-98. PubMed ID: 20200110
[TBL] [Abstract][Full Text] [Related]
25. Baseline prostate-specific antigen testing at a young age.
Loeb S; Carter HB; Catalona WJ; Moul JW; Schroder FH
Eur Urol; 2012 Jan; 61(1):1-7. PubMed ID: 21862205
[TBL] [Abstract][Full Text] [Related]
26. Why the evidence for skin cancer screening is insufficient: lessons from prostate cancer screening.
Bigby M
Arch Dermatol; 2010 Mar; 146(3):322-4. PubMed ID: 20231506
[No Abstract] [Full Text] [Related]
27. Critical appraisal of prostate-specific antigen in prostate cancer screening: 20 years later.
Pienta KJ
Urology; 2009 May; 73(5 Suppl):S11-20. PubMed ID: 19375622
[TBL] [Abstract][Full Text] [Related]
28. Prostate cancer screening: what's a fellow to do?
Thanel FH; Huntington MK
S D Med; 2010; Spec No():41-5. PubMed ID: 20397489
[TBL] [Abstract][Full Text] [Related]
29. A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam.
Roobol MJ; Zhu X; Schröder FH; van Leenders GJ; van Schaik RH; Bangma CH; Steyerberg EW
Eur Urol; 2013 Apr; 63(4):627-33. PubMed ID: 22841675
[TBL] [Abstract][Full Text] [Related]
30. Comment on the US Preventive Services Task Force's draft recommendation on screening for prostate cancer.
Kwiatkowski M; Klotz L; Hugosson J; Recker F
Eur Urol; 2012 Apr; 61(4):851-4. PubMed ID: 22285762
[No Abstract] [Full Text] [Related]
31. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
[TBL] [Abstract][Full Text] [Related]
32. PSA screening: determinants of primary-care physician practice patterns.
Tasian GE; Cooperberg MR; Potter MB; Cowan JE; Greene KL; Carroll PR; Chan JM
Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):189-94. PubMed ID: 22343837
[TBL] [Abstract][Full Text] [Related]
33. Summaries for patients. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
Ann Intern Med; 2013 May; 158(10):I-28. PubMed ID: 23567761
[No Abstract] [Full Text] [Related]
34. Clinical practice. Screening for prostate cancer.
Hoffman RM
N Engl J Med; 2011 Nov; 365(21):2013-9. PubMed ID: 22029754
[No Abstract] [Full Text] [Related]
35. Prostate cancer screening: issues and controversies.
O'Shaughnessy M; Konety B; Warlick C
Minn Med; 2010 Aug; 93(8):39-44. PubMed ID: 20862878
[TBL] [Abstract][Full Text] [Related]
36. The impact of interscreening interval and age on prostate cancer screening with prostate-specific antigen.
Wu GH; Auvinen A; Yen AM; Hakama M; Tammela TL; Stenman UH; Kujala P; Ruutu M; Chen HH
Eur Urol; 2012 May; 61(5):1011-8. PubMed ID: 22264679
[TBL] [Abstract][Full Text] [Related]
37. Prostate cancer screening 2010: updated recommendations from the American Cancer Society.
Brooks DD; Wolf A; Smith RA; Dash C; Guessous I
J Natl Med Assoc; 2010 May; 102(5):423-9. PubMed ID: 20533778
[TBL] [Abstract][Full Text] [Related]
38. Prostate cancer trends in southeast Michigan 1973-1992.
Demers RY
In Vivo; 1994; 8(3):429-31. PubMed ID: 7528558
[TBL] [Abstract][Full Text] [Related]
39. Prostate-specific antigen tests and prostate cancer screening: an update for primary care physicians.
Kell JS
Can J Urol; 2010 Feb; 17 Suppl 1():18-25. PubMed ID: 20170597
[TBL] [Abstract][Full Text] [Related]
40. Randomized trial results did not resolve controversies surrounding prostate cancer screening.
Hoffman RM
Curr Opin Urol; 2010 May; 20(3):189-93. PubMed ID: 20224414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
